Spinal Muscular Atrophy (SMA)

NINS Director Professor Dr Quazi Deen Mohammed, Roche Bangladesh Country Manager Mark Heeb and Radiant Pharmaceuticals Chairman Md Nasser Shahriar Zahedi signed the agreement on behalf of their respective sides in Dhaka on Tuesday (14 November).
Health

Agreement signed to expand rare genetic disease SMA treatment options in Bangladesh

So far, 160 patients have been reported to be affected by SMA in Bangladesh

Photo: TBS
Health

Toddler Raihan gets Tk22cr worth gene therapy free of cost